{
  "<p>Proof of delivery (POD) is a Supplier Standard and DMEPOS suppliers are required to maintain POD documentation in their files. Proof of delivery documentation must be made available to the Medicare contractor upon request. All services that do not have appropriate proof of delivery from the supplier shall be denied as not reasonable and necessary.<br /><br />REFILL REQUIREMENTS<br /><br /><span style=\"\"line-height: 107%;\"\">For DMEPOS items and supplies provided on a recurring basis": {
    "lcd_id": "<p>Proof of delivery (POD) is a Supplier Standard and DMEPOS suppliers are required to maintain POD documentation in their files. Proof of delivery documentation must be made available to the Medicare contractor upon request. All services that do not have appropriate proof of delivery from the supplier shall be denied as not reasonable and necessary.<br /><br />REFILL REQUIREMENTS<br /><br /><span style=\"\"line-height: 107%;\"\">For DMEPOS items and supplies provided on a recurring basis",
    "display_id": "",
    "title": " not retrospective use. For DMEPOS products that are supplied as refills to the original order",
    "status": "",
    "effective_date": " even if a",
    "contractors": [],
    "indication_summary": "and to confirm any changes or modifications to the order. Contact with the beneficiary or designee regarding refills must take place no sooner than 30 calendar days prior to the expected end of the current supply. For delivery of refills",
    "diagnoses_summary": "the supplier must deliver the DMEPOS product no sooner than 10 calendar days prior to the expected end of the current supply. This is regardless of which delivery method is utilized. For all DMEPOS items that are provided on a recurring basis",
    "coding_summary": "a supplier must not dispense more than a three (3) month quantity at a time. \"",
    "documentation_summary": ""
  },
  "<p>Proof of delivery (POD) is a Supplier Standard and DMEPOS suppliers are required to maintain POD documentation in their files. Proof of delivery documentation must be made available to the Medicare contractor upon request. All services that do not have appropriate proof of delivery from the supplier shall be denied as not reasonable and necessary.<br /><br />REFILL REQUIREMENTS<br /><br />For DMEPOS items and supplies provided on a recurring basis": {
    "lcd_id": "<p>Proof of delivery (POD) is a Supplier Standard and DMEPOS suppliers are required to maintain POD documentation in their files. Proof of delivery documentation must be made available to the Medicare contractor upon request. All services that do not have appropriate proof of delivery from the supplier shall be denied as not reasonable and necessary.<br /><br />REFILL REQUIREMENTS<br /><br />For DMEPOS items and supplies provided on a recurring basis",
    "display_id": "",
    "title": " not retrospective use. For DMEPOS products that are supplied as refills to the original order",
    "status": "",
    "effective_date": " even if a",
    "contractors": [],
    "indication_summary": "and to confirm any changes or modifications to the order. Contact with the beneficiary or designee regarding refills must take place no sooner than 30 calendar days prior to the expected end of the current supply. For delivery of refills",
    "diagnoses_summary": "the supplier must deliver the DMEPOS product no sooner than 10 calendar days prior to the expected end of the current supply. This is regardless of which delivery method is utilized. For all DMEPOS items that are provided on a recurring basis",
    "coding_summary": "a supplier must not dispense more than a three (3) - month quantity at a time. DRUG WASTAGE Claims for drugs billed to Medicare must use drug dosage formulations and/or unit dose sizes that minimize wastage. Medicare provides payment for the amount of a single use vial or other single use package of drug or biological discarded",
    "documentation_summary": "in addition to the dose administered. (See the MODIFIERS section of the Nebulizers LCD-related Policy Article.) \""
  },
  "<p>Retreatment may be considered for patients who met the guidelines for initial treatment and subsequently developed relapse of depressive symptoms if the patient responded to prior treatments as evidenced by a greater than 50% improvement in standard rating scale measurements for depressive symptoms.</p>\"": {
    "lcd_id": "<p>Retreatment may be considered for patients who met the guidelines for initial treatment and subsequently developed relapse of depressive symptoms if the patient responded to prior treatments as evidenced by a greater than 50% improvement in standard rating scale measurements for depressive symptoms.</p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "2023-02-09 00:00:00",
    "documentation_summary": ""
  },
  "<p style=\"\"margin: 0in 0in 10pt;\"\"><span style=\"\"font-family: Times New Roman; font-size: medium;\"\"><span style=\"\"color: black; line-height: 115%; font-family: 'Verdana'": {
    "lcd_id": "<p style=\"\"margin: 0in 0in 10pt;\"\"><span style=\"\"font-family: Times New Roman; font-size: medium;\"\"><span style=\"\"color: black; line-height: 115%; font-family: 'Verdana'",
    "display_id": "N",
    "title": " CT thorax should be provided by qualified radiology personnel (radiology technicians",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": "N/A"
  },
  "</ul>\"": {
    "lcd_id": "</ul>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "1.AANEM. Position Statement, Proper performance and interpretation of electrodiagnostic studies. Approved June 2014. Available at aanem.org 2. AANEM. Position Statement, Risks in electrodiagnostic medicine. Approved July 2014. Available at aanem.org 3. AANEM. Recommended Policy for Electrodiagnostic Medicine. Updated on 08/30/2014. Available at aanem.org 4. ABPTS, 2016 Clinical Electrophysiology Specialist Certification Candidate Guide. Available at: abpts.org. 5. Brown E. An Evidence Based Tech",
    "coding_summary": "2017-01-19 00:00:00",
    "documentation_summary": ""
  },
  "<p>&nbsp;</p>\"": {
    "lcd_id": "<p>&nbsp;</p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "2020-02-15 00:00:00",
    "documentation_summary": ""
  },
  "<p>Claims for drugs billed to Medicare must use drug dosage formulations and/or unit dose sizes that minimize wastage. Medicare provides payment for the amount of a single use vial or other single use package of drug or biological discarded": {
    "lcd_id": "<p>Claims for drugs billed to Medicare must use drug dosage formulations and/or unit dose sizes that minimize wastage. Medicare provides payment for the amount of a single use vial or other single use package of drug or biological discarded",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "2025-09-06 00:00:00",
    "documentation_summary": ""
  },
  "<p>Regardless of utilization": {
    "lcd_id": "<p>Regardless of utilization",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "2025-10-11 00:00:00",
    "documentation_summary": ""
  },
  "<p><strong> Indications:</strong><br /><br />A<span style=\"\"line-height: 107%;\"\"> diagnostic ultrasound A-scan generally is used for patients who have simple cataracts.</span><span style=\"\"line-height: 107%;\"\"> For patients with a dense cataract": {
    "lcd_id": "<p><strong> Indications:</strong><br /><br />A<span style=\"\"line-height: 107%;\"\"> diagnostic ultrasound A-scan generally is used for patients who have simple cataracts.</span><span style=\"\"line-height: 107%;\"\"> For patients with a dense cataract",
    "display_id": "",
    "title": " <em>Medicare National Coverage Determinations(NCD)Manual</em>",
    "status": "",
    "effective_date": " unaffilia",
    "contractors": [],
    "indication_summary": "the relative value units (RVUs) for the global and technical components of each method of ophthalmic biometry for intraocular lens power calculation are based on the procedure being bilaterally performed. If unilateral cataract extraction with an IOL implant is planned",
    "diagnoses_summary": "a bilateral technical component of the A-scan or OCB is typically performed",
    "coding_summary": "allowance for the power calculation can be made. However",
    "documentation_summary": "allowance for the technical component of the A-scan or OCB CPT code cannot be made since this bilateral procedure was performed and reimbursed at the time of the first surgery. The technical component of the scan will generally provide valid information for twelve months. A repeat scan in less than twelve months would not be covered without documentation of significant change in vision (unless required because a second unaffiliated surgeon performed the second cataract extraction.) Generally"
  },
  "<p>United Healthcare": {
    "lcd_id": "<p>United Healthcare",
    "display_id": "",
    "title": " 99-14",
    "status": "",
    "effective_date": " 99-18",
    "contractors": [],
    "indication_summary": "99-20",
    "diagnoses_summary": "99-21; pub. October",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>OnabotulinumtoxinA is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence": {
    "lcd_id": "<p>OnabotulinumtoxinA is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence",
    "display_id": "2017-08-21 00:00:00",
    "title": " and frequency",
    "status": "",
    "effective_date": " consecuti",
    "contractors": [],
    "indication_summary": "however",
    "diagnoses_summary": "to attempt treatment with a different serotype. Treatment of wrinkles using Botulinum toxins is considered to be cosmetic",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br />This LCD outlines the indications for Vitamin D": {
    "lcd_id": "<p><br />This LCD outlines the indications for Vitamin D",
    "display_id": "A",
    "title": " 1",
    "status": "",
    "effective_date": " Chapter 1",
    "contractors": [],
    "indication_summary": "Medicare Program Integrity Manual",
    "diagnoses_summary": "Chapter 13",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br />If all of the criteria are not met": {
    "lcd_id": "<p><br />If all of the criteria are not met",
    "display_id": "",
    "title": " A7025 and A7026",
    "status": "",
    "effective_date": " the claim",
    "contractors": [],
    "indication_summary": "Orthotics and Supplies (DMEPOS) base items that require a Written Order Prior to Delivery (WOPD)",
    "diagnoses_summary": "the supplier must have received a signed SWO before the DMEPOS item is delivered to a beneficiary. If a supplier delivers a DMEPOS item without first receiving a WOPD",
    "coding_summary": "accessories",
    "documentation_summary": "and/or supplies"
  },
  "<p>If one of these criteria is not met": {
    "lcd_id": "<p>If one of these criteria is not met",
    "display_id": "",
    "title": " very heavy duty",
    "status": "",
    "effective_date": " for extra",
    "contractors": [],
    "indication_summary": "the delivery must be within 6 months following the determination. An add-on to convert a manual wheelchair to a joystick-controlled power mobility device (E0983) or to a tiller-controlled power mobility device (E0984) will be denied as not reasonable and necessary. Payment is made for only one wheelchair at a time. Backup chairs are denied as not reasonable and necessary. One month's rental of a PWC or POV (K0462) is covered if a beneficiary-owned wheelchair is being repaired. Payment is based o",
    "diagnoses_summary": "following lower extremity surgery which limits ambulation). A POV or PWC which has not been reviewed by the Pricing",
    "coding_summary": "LCD-related Policy Articles",
    "documentation_summary": "or DME MAC articles. Claims that do not meet coding guidelines shall be denied as not reasonable and necessary/incorrectly coded. Proof of delivery (POD) is a Supplier Standard and DMEPOS suppliers are required to maintain POD documentation in their files. Proof of delivery documentation must be made available to the Medicare contractor upon request. All services that do not have appropriate proof of delivery from the supplier shall be denied as not reasonable and necessary. \""
  },
  "<p>The evaluation should be tailored to the individual beneficiary&#8217;s conditions. The history should paint a picture of the beneficiary&#8217;s functional abilities and limitations on a typical day. It should contain as much objective data as possible. The physical examination should be focused on the body systems that are responsible for the beneficiary&#8217;s ambulatory difficulty or impact on the beneficiary's ambulatory ability.<br /><br />The written report of this encounter must be available upon request.<br /><br />Practitioners shall document the encounter in a detailed narrative note in their charts in the format that they use for other entries. The note must clearly indicate that a major reason for the visit was a mobility encounter. <br /><br />Many suppliers have created forms which have not been approved by CMS which they send to practitioners and ask them to complete. Even if the treating practitioner completes this type of form and puts it in his/her chart": {
    "lcd_id": "<p>The evaluation should be tailored to the individual beneficiary&#8217;s conditions. The history should paint a picture of the beneficiary&#8217;s functional abilities and limitations on a typical day. It should contain as much objective data as possible. The physical examination should be focused on the body systems that are responsible for the beneficiary&#8217;s ambulatory difficulty or impact on the beneficiary's ambulatory ability.<br /><br />The written report of this encounter must be available upon request.<br /><br />Practitioners shall document the encounter in a detailed narrative note in their charts in the format that they use for other entries. The note must clearly indicate that a major reason for the visit was a mobility encounter. <br /><br />Many suppliers have created forms which have not been approved by CMS which they send to practitioners and ask them to complete. Even if the treating practitioner completes this type of form and puts it in his/her chart",
    "display_id": "",
    "title": " x-rays",
    "status": "",
    "effective_date": " electromy",
    "contractors": [],
    "indication_summary": "suppliers shall provide notes from prior visits to give a historical perspective of the progression of disease over time and to corroborate the information in the face-to-face encounter. If the report of a licensed/certified medical professional (LCMP) examination is to be considered as part of the face-to-face encounter (see Policy Article)",
    "diagnoses_summary": "there must be a signed and dated attestation by the supplier or LCMP that the LCMP has no financial relationship with the supplier. (Note: Evaluations performed by an LCMP who has a financial relationship with the supplier may be submitted to provide additional clinical information",
    "coding_summary": "any Group 3 PWC",
    "documentation_summary": "or a power assist system is in addition to the requirement for the face-to-face encounter. The specialty evaluation provides detailed information explaining why each specific option or accessory \u2013 i.e."
  },
  "<p><br />REFILL REQUIREMENTS<br /><br />For DMEPOS items and supplies provided on a recurring basis": {
    "lcd_id": "<p><br />REFILL REQUIREMENTS<br /><br />For DMEPOS items and supplies provided on a recurring basis",
    "display_id": "",
    "title": " not retrospective use. For DMEPOS products that are supplied as refills to the original order",
    "status": "",
    "effective_date": " even if a",
    "contractors": [],
    "indication_summary": "and to confirm any changes or modifications to the order. Contact with the beneficiary or designee regarding refills must take place no sooner than 30 calendar days prior to the expected end of the current supply. For delivery of refills",
    "diagnoses_summary": "the supplier must deliver the DMEPOS product no sooner than 10 calendar days prior to the expected end of the current supply. This is regardless of which delivery method is utilized. For all DMEPOS items that are provided on a recurring basis",
    "coding_summary": "a supplier must not dispense more than a one (1)-month quantity at a time. \"",
    "documentation_summary": ""
  },
  "<p>Suppliers must not dispense a quantity of supplies exceeding a beneficiary's expected utilization. Suppliers must stay attuned to changed or atypical utilization patterns on the part of their clients. Suppliers must verify with the&nbsp;treating practitioners that any changed or atypical utilization is warranted. Regardless of utilization": {
    "lcd_id": "<p>Suppliers must not dispense a quantity of supplies exceeding a beneficiary's expected utilization. Suppliers must stay attuned to changed or atypical utilization patterns on the part of their clients. Suppliers must verify with the&nbsp;treating practitioners that any changed or atypical utilization is warranted. Regardless of utilization",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br /><br />REFILL REQUIREMENTS<br /><br /><span style=\"\"line-height: 107%;\"\">For DMEPOS items and supplies provided on a recurring basis": {
    "lcd_id": "<p><br /><br />REFILL REQUIREMENTS<br /><br /><span style=\"\"line-height: 107%;\"\">For DMEPOS items and supplies provided on a recurring basis",
    "display_id": "",
    "title": " not retrospective use. For DMEPOS products that are supplied as refills to the original order",
    "status": "",
    "effective_date": " even if a",
    "contractors": [],
    "indication_summary": "and to confirm any changes or modifications to the order. Contact with the beneficiary or designee regarding refills must take place no sooner than 30 calendar days prior to the expected end of the current supply. For delivery of refills",
    "diagnoses_summary": "the supplier must deliver the DMEPOS product no sooner than 10 calendar days prior to the expected end of the current supply. This is regardless of which delivery method is utilized. For all DMEPOS items that are provided on a recurring basis",
    "coding_summary": "a supplier must not dispense more than a one (1) -month supply at a time for a beneficiary in a nursing facility and a three (3) -month supply for a beneficiary at home. For information on tracheostomy supplies",
    "documentation_summary": "see the Tracheostomy Care Supplies policy. \""
  },
  "<p><br />REFILL REQUIREMENTS<br /><br /><span style=\"\"line-height: 107%;\"\">For DMEPOS items and supplies provided on a recurring basis": {
    "lcd_id": "<p><br />REFILL REQUIREMENTS<br /><br /><span style=\"\"line-height: 107%;\"\">For DMEPOS items and supplies provided on a recurring basis",
    "display_id": "",
    "title": " not retrospective use. For DMEPOS products that are supplied as refills to the original order",
    "status": "",
    "effective_date": " even if a",
    "contractors": [],
    "indication_summary": "and to confirm any changes or modifications to the order. Contact with the beneficiary or designee regarding refills must take place no sooner than 30 calendar days prior to the expected end of the current supply. For delivery of refills",
    "diagnoses_summary": "the supplier must deliver the DMEPOS product no sooner than 10 calendar days prior to the expected end of the current supply. This is regardless of which delivery method is utilized. For all DMEPOS items that are provided on a recurring basis",
    "coding_summary": "a supplier must not dispense more than a 1-month supply at a time for a beneficiary in a nursing facility and a 3-month supply for a beneficiary at home. For information on tracheal suction catheters and related supplies",
    "documentation_summary": "see the Suction Pump policy. \""
  },
  "<p>HCPCS code G0268 should be billed only where a physician's skill is needed to remove impacted cerumen on the same day as audiologic function testing performed by his/her employed audiologist. This code should not be used when the audiologist removes the cerumen": {
    "lcd_id": "<p>HCPCS code G0268 should be billed only where a physician's skill is needed to remove impacted cerumen on the same day as audiologic function testing performed by his/her employed audiologist. This code should not be used when the audiologist removes the cerumen",
    "display_id": "",
    "title": " experience or practice may include or require techniques of cerumen removal. However",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "This bibliography presents those sources that were obtained during the development of this policy. CGS Administrators, LLC. is not responsible for the continuing viability of Web site addresses listed below. McCarter DF, Courtney AU. Cerumen impaction. American Family Academy of Family Physician. >2007;75(10):10.",
    "documentation_summary": ""
  },
  "<p>For patients with a best-corrected visual acuity of 20/40 or better": {
    "lcd_id": "<p>For patients with a best-corrected visual acuity of 20/40 or better",
    "display_id": "A",
    "title": " and where a laser has been approved for marketing by the Food and Drug Administration",
    "status": "",
    "effective_date": " revise",
    "contractors": [],
    "indication_summary": "coverage of laser procedures is restricted to practitioners with training in the surgical management of the disease or condition being treated (CMS Publication 100-03",
    "diagnoses_summary": "Medicare National Coverage Determinations Manual",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>The &ldquo;Documentation Requirements&rdquo; section of the policy provides a list of diagnosis codes to be reported with CPT code 66982 in specified circumstances.<br /><br /><strong> Other Comments:</strong><br /><br />For claims submitted to the Part A MAC: This coverage determination also applies within states outside the primary geographic jurisdiction with facilities that have nominated CGS to process their claims.<br /><br />Bill type codes only apply to providers who bill these services to the Part A MAC. Bill type codes do not apply to physicians": {
    "lcd_id": "<p>The &ldquo;Documentation Requirements&rdquo; section of the policy provides a list of diagnosis codes to be reported with CPT code 66982 in specified circumstances.<br /><br /><strong> Other Comments:</strong><br /><br />For claims submitted to the Part A MAC: This coverage determination also applies within states outside the primary geographic jurisdiction with facilities that have nominated CGS to process their claims.<br /><br />Bill type codes only apply to providers who bill these services to the Part A MAC. Bill type codes do not apply to physicians",
    "display_id": "",
    "title": " whether based on medical necessity or other coverage reasons. The provider/supplier must notify the beneficiary in writing",
    "status": "",
    "effective_date": " item or p",
    "contractors": [],
    "indication_summary": "references to \"\"physicians\"\" throughout this policy include non-physicians",
    "diagnoses_summary": "such as nurse practitioners",
    "coding_summary": "order and establish the plan of care for cataract extraction services as authorized by State law. (See Sections 1861[s][2] and 1862[a][14] of Title XVIII of the Social Security Act; 42 CFR",
    "documentation_summary": "Sections 410.74"
  },
  "<p><em> <u> and the likelihood that the results of the cardiac testing would change the management.</u></em>Evaluation of ventricular function in patients with non-ischemic myocardial disease;<br /><br />Evaluation of patients in whom an accurate measure of the ejection fraction is needed to make a determination of whether to implant a defibrillator or biventricular pacemaker;<br /><br />Evaluation of a patient receiving chemotherapeutic drugs which are potentially cardiotoxic (e.g.": {
    "lcd_id": "<p><em> <u> and the likelihood that the results of the cardiac testing would change the management.</u></em>Evaluation of ventricular function in patients with non-ischemic myocardial disease;<br /><br />Evaluation of patients in whom an accurate measure of the ejection fraction is needed to make a determination of whether to implant a defibrillator or biventricular pacemaker;<br /><br />Evaluation of a patient receiving chemotherapeutic drugs which are potentially cardiotoxic (e.g.",
    "display_id": "",
    "title": " and has not been previously obtained or likely to be obtained from other planned tests such as echocardiography or equilibrium gated blood pool studies. First pass studies may be indicated for the as",
    "status": "",
    "effective_date": " low photo",
    "contractors": [],
    "indication_summary": "in light of the predictive value of exercise-induced changes in ejection fraction",
    "diagnoses_summary": "an exception will be made to allow first pass",
    "coding_summary": "cardiac abnormalities on physical examination",
    "documentation_summary": "or abnormalities on cardiac testing (e.g."
  },
  "<p><strong> Limitations:</strong><br /><br />Corneal topography will only be allowed for a pre-operative cataract patient if documentation supports that the patient has irregular astigmatism. Its use for this purpose should be rare.<br /><br />Corneal topography is to be billed only when the diagnosis of monocular diplopia is thought to be caused by a corneal irregularity.<br /><br />Corneal topography is a covered service for the above indications when medically reasonable and necessary only if the results will assist in defining further treatment. It is not covered for routine follow-up testing.<br /><br />Repeat testing is only indicated if a change of vision is reported in connection with one of the above listed conditions.<br /><br />Services performed for screening purposes or in the absence of associated signs": {
    "lcd_id": "<p><strong> Limitations:</strong><br /><br />Corneal topography will only be allowed for a pre-operative cataract patient if documentation supports that the patient has irregular astigmatism. Its use for this purpose should be rare.<br /><br />Corneal topography is to be billed only when the diagnosis of monocular diplopia is thought to be caused by a corneal irregularity.<br /><br />Corneal topography is a covered service for the above indications when medically reasonable and necessary only if the results will assist in defining further treatment. It is not covered for routine follow-up testing.<br /><br />Repeat testing is only indicated if a change of vision is reported in connection with one of the above listed conditions.<br /><br />Services performed for screening purposes or in the absence of associated signs",
    "display_id": "2025-01-08 00:00:00",
    "title": " illness or injury as indicated above",
    "status": "",
    "effective_date": " LLC. to p",
    "contractors": [],
    "indication_summary": "prior to rendering the service",
    "diagnoses_summary": "if the provider/supplier is aware that the test",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br /><strong> Other Comments:</strong><br /><br />For claims submitted to the Part A MAC: this coverage determination also applies within states outside the primary geographic jurisdiction with facilities that have nominated CGS Administrators": {
    "lcd_id": "<p><br /><strong> Other Comments:</strong><br /><br />For claims submitted to the Part A MAC: this coverage determination also applies within states outside the primary geographic jurisdiction with facilities that have nominated CGS Administrators",
    "display_id": "2025-07-29 14:49:01.210000000",
    "title": " other professionals and suppliers who bill these services to the carrier or Part B MAC.<br /><br />Limitation of liability and refund requirements apply when denials are likely",
    "status": "",
    "effective_date": " item or p",
    "contractors": [],
    "indication_summary": "has no Medicare benefit category or is rendered for screening purposes. For dates of service on or after April 1",
    "diagnoses_summary": "2010",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>CMS Publication 100-09": {
    "lcd_id": "<p>CMS Publication 100-09",
    "display_id": "",
    "title": "</em> Chapter 5: Correct Coding Initiative.<br /><br />CMS Transmittal AB-00-44",
    "status": "",
    "effective_date": " June 2000",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "</ol>\"": {
    "lcd_id": "</ol>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "This bibliography presents those sources that were obtained during the development of this policy. CGS Administrators, LLC is not responsible for the continuing viability of Web site addresses listed below. Benign Prostatic Hyperplasia (BPH)/Enlarged Prostate \u2013 Thermal Treatments, June 10, 1998. urologychannel\u00ae Web site. http://www.urologychannel.com/prostate/bph/treatment_therm.shtml. Accessed October 13, 2009. Keoghane SR, Lawrence KC, Gray AM, et al. A double-blind randomized controlled trial",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br /><br /><strong>NOTE:</strong> If both a blepharoplasty and a ptosis repair are planned": {
    "lcd_id": "<p><br /><br /><strong>NOTE:</strong> If both a blepharoplasty and a ptosis repair are planned",
    "display_id": "<p><em><strong>Other requirements</strong></em><br />The medical record documentation must support the medical necessity of the services as directed in this policy.<br /><br />All documentation must be maintained in the patient&rsquo;s medical record and available to the contractor upon request.<br /><br />Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service(s)). <br /><br />Documentation must support CMS &lsquo;signature requirements&rsquo; as described in the Medicare Program Integrity Manual (Pub. 100-08), Chapter 3.<br /><br />A pre-operative exam and operative report must be available.<br /><br />The submitted medical record must support the use of the selected ICD10-CM code(s). The submitted CPT/HCPCS code must describe the service performed. <br /><br /></p>",
    "title": " but not necessarily) require two sets of photographs: showing a pseudo-MRD of 2.0 mm or less secondary to the redundant skin (and its correction by taping)",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><em>The services of other practitioners (including clinical social workers and occupational therapists)": {
    "lcd_id": "<p><em>The services of other practitioners (including clinical social workers and occupational therapists)",
    "display_id": "<p>This bibliography presents those sources that were obtained during the development of this policy. CGS Administrators, LLC is not responsible for the continuing viability of Web site addresses listed below.<br /><br />American Psychiatric Association, <em>Diagnostic and Statistical Manual of Mental Disorders</em>. 4th ed. Washington, DC: American Psychiatric Association; 2000.<br /><br />Block BM, Lefkovitz PM. <em>Standards and Guidelines for Partial Hospitalization</em>. Alexandria, VA: American Association for Partial Hospitalization, Inc; [no date].<br /><br />Block BM, Lefkovitz PM. <em>Standards and Guidelines for Partial Hospitalization: Adult Programs.</em> 2nd ed. Alexandria, VA: American Association for Partial Hospitalization, Inc; 1994.<br /><br />Block BM, Lefkovitz PM. <em>Standards and Guidelines for Partial Hospitalization: Chemical Dependency Programs.</em> Alexandria, VA: Association for Ambulatory Behavioral Healthcare; 1996.<br /><br />Gartner L, Mee-Lee D. The role and current status of patient placement criteria in the treatment of substance abuse disorders. U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center For Substance Abuse Treatment. Rockville, MD. [no date]<br /><br />Green Spring Health Services. Utilization review criteria. Green Spring Health Services, Inc; 1992.<br /><br />Kiser LJ, Barksdale SH. <em>Overview of the partial hospitalization industry: an analysis of the data from the 1994 National Program Survey</em>. Alexandria, VA: Association for Ambulatory Behavioral Healthcare, Inc; 1996.<br /><br />National Quality Monitoring Program. Mental health quality monitoring screens and utilization review criteria. Science Applications International Corporation; November, 1995.<br /><br />Wagner BD, Plotkin D, Lefkovitz PM, Block BM. <em>Standards and Guidelines for Partial Hospitalization: Geriatric Partial Hospitalization.</em> Alexandria, VA: American Association for Partial Hospitalization, Inc; 1993.<br /><br />Washington Peer Review Organization. Admission and discharge review criteria for psychiatric hospitalization. [no date]</p>",
    "title": " including partial hospitalization patients. The hospital must bill</em> [their FI] <em> for such nonphysician practitioner services as partial hospitalization services. [P]ayment for the services</em",
    "status": "",
    "effective_date": " SNF",
    "contractors": [],
    "indication_summary": "if a physician is the employer of the PA and the PA renders services in the hospital",
    "diagnoses_summary": "the physician and not the hospital is responsible for billing the carrier on Form CMS 1500 for the services of the PA (CMS Publication 100-04",
    "coding_summary": "physician assistants",
    "documentation_summary": "nurse practitioners"
  },
  "<p>CMS Publication 100-02": {
    "lcd_id": "<p>CMS Publication 100-02",
    "display_id": "N",
    "title": " <em>Medicare Claims Processing Manual</em>",
    "status": "",
    "effective_date": " January 2",
    "contractors": [],
    "indication_summary": "Transmittal No. 98",
    "diagnoses_summary": "Change Request #3343",
    "coding_summary": "2003. CMS Publication 100-04",
    "documentation_summary": "Medicare Claims Processing Manual"
  },
  "<p><strong> Payment for more than one professional component (PC) of a single lumbar MRI:</strong><br /><br />Medicare will not pay twice for service that is required only once to diagnose or treat an illness or injury. Typically": {
    "lcd_id": "<p><strong> Payment for more than one professional component (PC) of a single lumbar MRI:</strong><br /><br />Medicare will not pay twice for service that is required only once to diagnose or treat an illness or injury. Typically",
    "display_id": "A",
    "title": " such as to clarify a questionable finding. The physician performing the initial PC must have a valid reason to require another physician's expertise",
    "status": "",
    "effective_date": " this A/B ",
    "contractors": [],
    "indication_summary": "written report similar to one that is prepared by a specialist in the field. The content of the written report must address the relevant clinical issues",
    "diagnoses_summary": "available comparative data",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br /><br /><strong> The following are noncovered antigens:</strong> newsprint": {
    "lcd_id": "<p><br /><br /><strong> The following are noncovered antigens:</strong> newsprint",
    "display_id": "",
    "title": " dandelion",
    "status": "",
    "effective_date": " sugar",
    "contractors": [],
    "indication_summary": "grain mill dust",
    "diagnoses_summary": "soybean dust (except when the patient has a known exposure to soybean dust such as a food processing plant)",
    "coding_summary": "or chalk. \"",
    "documentation_summary": ""
  },
  "<p>Effective for claims with dates of service on and after January 1": {
    "lcd_id": "<p>Effective for claims with dates of service on and after January 1",
    "display_id": "2025-02-24 00:00:00",
    "title": " non-ESRD ESA services billed with modifier EB (ESA",
    "status": "",
    "effective_date": " 2008",
    "contractors": [],
    "indication_summary": "anemia",
    "diagnoses_summary": "chemo-induced) for anemia secondary to myelosuppressive anticancer chemotherapy in solid tumors",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br /><br /></p>\"": {
    "lcd_id": "<p><br /><br /></p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "This bibliography presents those sources that were obtained during the development of this policy. National Government Services is not responsible for the continuing viability of Web site addresses listed below. 1. Fortin JD, Aprill CN, Ponthieux B, Pier J. Sacroiliac joint: pain referral maps upon applying a new injection/arthrography technique. Part II: Clinical evaluation, Spine. 1994;19:1483-9. 2. Fortin JD, Dwyer AP, West S, Pier J. Joint: pain referral maps upon applying a new injection/ar",
    "coding_summary": "2016-02-15 00:00:00",
    "documentation_summary": ""
  },
  "<p><strong> Limitations:</strong><br /><br />Gross visual field testing (e.g.": {
    "lcd_id": "<p><strong> Limitations:</strong><br /><br />Gross visual field testing (e.g.",
    "display_id": "",
    "title": " whether based on medical necessity or other coverage reasons. The provider/supplier must notify the beneficiary in writing",
    "status": "",
    "effective_date": " item or p",
    "contractors": [],
    "indication_summary": "references to \"\"physicians\"\" throughout this policy include non-physicians",
    "diagnoses_summary": "such as nurse practitioners",
    "coding_summary": "order and establish the plan of care as authorized by State law. (See Sections 1861[s][2] and 1862[a][14] of Title XVIII of the Social Security Act; 42 CFR",
    "documentation_summary": "Sections 410.74"
  },
  "<p>CMS Transmittal No. 1770": {
    "lcd_id": "<p>CMS Transmittal No. 1770",
    "display_id": "N",
    "title": " <em>Medicare Claims Processing Manual</em>",
    "status": "",
    "effective_date": " Medicare ",
    "contractors": [],
    "indication_summary": "clinical modification (ICD-9-CM). \"",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": "The patient's medical record must contain documentation that fully supports the medical necessity for services included within this LCD. (See \"Indications and Limitations of Coverage.\") This documentation includes, but is not limited to, relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures."
  },
  "<p><strong>When a noncovered cosmetic procedure is performed in the same operative session</strong> as a covered surgical procedure": {
    "lcd_id": "<p><strong>When a noncovered cosmetic procedure is performed in the same operative session</strong> as a covered surgical procedure",
    "display_id": "N",
    "title": " if blepharochalasis could be resolved sufficiently by brow ptosis repair alone",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": "N/A"
  },
  "<p><u>Fluorescein</u><br /><br />Studies performed for screening will be denied by Medicare as not medically necessary.<br /><br />Fluorescein angiography must be performed under the direct supervision (physician present in the office and immediately available) of a physician when done by a non-physician practitioner. <br /><br />If excluded by State law": {
    "lcd_id": "<p><u>Fluorescein</u><br /><br />Studies performed for screening will be denied by Medicare as not medically necessary.<br /><br />Fluorescein angiography must be performed under the direct supervision (physician present in the office and immediately available) of a physician when done by a non-physician practitioner. <br /><br />If excluded by State law",
    "display_id": "",
    "title": " in patients with unilateral AMD or other disease",
    "status": "",
    "effective_date": " will be d",
    "contractors": [],
    "indication_summary": "if the provider/supplier is aware that the test",
    "diagnoses_summary": "item or procedure may not be considered medically necessary by Medicare. The limitation of liability and refund requirements do not apply when the test",
    "coding_summary": "such as nurse practitioners",
    "documentation_summary": "clinical nurse specialists and physician assistants. Such non-physician practitioners"
  },
  "<p>Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. <em>Arch Ophthalmol</em>. 1992;110(12):1701-1708.<br /><br />Singh RP": {
    "lcd_id": "<p>Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. <em>Arch Ophthalmol</em>. 1992;110(12):1701-1708.<br /><br />Singh RP",
    "display_id": "",
    "title": " Giovannini A",
    "status": "",
    "effective_date": " Hamilton ",
    "contractors": [],
    "indication_summary": "Maguire MG",
    "diagnoses_summary": "Schachat AP",
    "coding_summary": "Sallet G",
    "documentation_summary": "De Laey JJ. Indocyanine green angiography in cases of inflammatory chorioretinopathy. Bull Soc Belge Ophtalmol . 1995;257:73-81. Watzke RC"
  },
  "<p>Both the beneficiary's BMI and level of disability should be determined using measurements/observations made within&nbsp;6 months (180 days) of the most recent certification/recertification date. If enteral nutritional support has been instituted prior to the election of the Hospice Medicare Benefit and will be continued": {
    "lcd_id": "<p>Both the beneficiary's BMI and level of disability should be determined using measurements/observations made within&nbsp;6 months (180 days) of the most recent certification/recertification date. If enteral nutritional support has been instituted prior to the election of the Hospice Medicare Benefit and will be continued",
    "display_id": "<p><strong>Documentation Requirements</strong></p>",
    "title": " recumbent measurement(s) (anthropometry) such as mid-arm muscle area in cm<sup> 2</sup> may be substituted for BMI with documentation as to why a BMI could not be measured. This information will be s",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>2. The skills of an&nbsp;OT to assess and reassess a patient&rsquo;s rehabilitation needs and potential": {
    "lcd_id": "<p>2. The skills of an&nbsp;OT to assess and reassess a patient&rsquo;s rehabilitation needs and potential",
    "display_id": "",
    "title": " implementing and supervision of therapeutic programs (including",
    "status": "",
    "effective_date": " therapeut",
    "contractors": [],
    "indication_summary": "implementing and supervising of individualized therapeutic activity programs (as well as",
    "diagnoses_summary": "adapting to the environment) as part of an overall \u201cactive treatment\u201d program for a patient with a diagnosed psychiatric illness d. Assessing and planning for improved home safety. Maintenance Program Coverage of therapy services",
    "coding_summary": "Medicare Benefit Policy Manual",
    "documentation_summary": "Chapter 7"
  },
  "<p style=\"\"line-height: normal;\"\">The CMS Internet-Only Manual": {
    "lcd_id": "<p style=\"\"line-height: normal;\"\">The CMS Internet-Only Manual",
    "display_id": "A",
    "title": " Chapter 7 &sect;40.1.2.3 provides guidance in determining the reasonableness and necessity of the number of training visits and the appropriateness of re-teaching and re-training.<br /><br />In the H",
    "status": "",
    "effective_date": " family",
    "contractors": [],
    "indication_summary": "the services for teaching and training would be considered to be reasonable and necessary prior to the point that it became apparent that the teaching or training was unsuccessful",
    "diagnoses_summary": "as long as such services were appropriate to the patient's illness",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><strong>Sensory Integrative Techniques</strong><br /><br />Sensory integrative techniques are interventions generally intended for the pediatric and/or neurologically impaired populations. The focus of these activities is to train the sensory systems to modulate the vast array of incoming sensory stimuli. This is something that is normally performed without apparent effort. Once the patient/client learns to block the extrasensory 'noise'": {
    "lcd_id": "<p><strong>Sensory Integrative Techniques</strong><br /><br />Sensory integrative techniques are interventions generally intended for the pediatric and/or neurologically impaired populations. The focus of these activities is to train the sensory systems to modulate the vast array of incoming sensory stimuli. This is something that is normally performed without apparent effort. Once the patient/client learns to block the extrasensory 'noise'",
    "display_id": "",
    "title": " Pub. 100-03",
    "status": "",
    "effective_date": " &sect;170",
    "contractors": [],
    "indication_summary": "or work settings are not reasonable and necessary for the diagnosis and treatment of an illness or injury and are excluded from coverage by section 1862(a)(1)(A) of the Social Security Act. Wheelchair Management Training 1. This service trains the patient in functional activities that promote optimal safety",
    "diagnoses_summary": "mobility and transfers. Patients who are wheelchair bound may occasionally need skilled input on positioning to avoid pressure points",
    "coding_summary": "skin breakdown",
    "documentation_summary": "and falls). 3. These assessments may be reasonable and necessary for determining the patient's response to wearing the device"
  },
  "<p>3. Treatment plan updates should show the treatment plan to be reflective of active treatment": {
    "lcd_id": "<p>3. Treatment plan updates should show the treatment plan to be reflective of active treatment",
    "display_id": "Y",
    "title": " amount",
    "status": "",
    "effective_date": " progress ",
    "contractors": [],
    "indication_summary": "behavior",
    "diagnoses_summary": "verbalizations",
    "coding_summary": "and include the credentials of the rendering provider. It should be clear from the progress notes how the particular service relates to the overall plan of care. Physician Progress Notes: Physician progress notes should be recorded at each patient encounter and contain pertinent patient history",
    "documentation_summary": "changes in signs and symptoms with special attention to changes to the patient\u2019s mental status"
  },
  "<p>For outpatient settings other than Comprehensive Outpatient Rehabilitation Facility (CORF)s": {
    "lcd_id": "<p>For outpatient settings other than Comprehensive Outpatient Rehabilitation Facility (CORF)s",
    "display_id": "",
    "title": " such as nurse practitioners",
    "status": "",
    "effective_date": " may certi",
    "contractors": [],
    "indication_summary": "and establish the plan of care as authorized by State law. (See Sections 1861[s][2] and 1862[a][14] of Title XVIII of the Social Security Act; 42 CFR",
    "diagnoses_summary": "Sections 410.74",
    "coding_summary": "2000.) Each practitioner must provide only those services within the scope of practice for each state. \"",
    "documentation_summary": ""
  },
  "<p>The benefits of intraoperative neurophysiologic testing are attainable under optimal recording and interpreting conditions. <br /><br />Due to the nature of these services and the potential for significant morbidity in some procedures requiring intraoperative monitoring": {
    "lcd_id": "<p>The benefits of intraoperative neurophysiologic testing are attainable under optimal recording and interpreting conditions. <br /><br />Due to the nature of these services and the potential for significant morbidity in some procedures requiring intraoperative monitoring",
    "display_id": "",
    "title": " continuous communication between the anesthesiologist and the monitoring physician is expected when medically indicated.<br /><br />It is also expected that a specifically trained technician",
    "status": "",
    "effective_date": " with eith",
    "contractors": [],
    "indication_summary": "as long as a trained technician (see detail above) will be in continuous attendance in the operating room",
    "diagnoses_summary": "with either the physical or electronic capacity for real-time communication with the supervising physician (MD/DO). Technical criteria (mandatory) include that at least 8 recording channels be available (16 if EEG is monitored) for all intraoperative neurophysiological monitoring. The remotely supervising physician must have the ability to watch the tracings as they are obtained in real-time in the operating room",
    "coding_summary": "electroencephalography/electrocorticography",
    "documentation_summary": "electromyography and nerve conduction"
  },
  "<p>All other uses of Transcranial Magnetic Stimulation are experimental and are not covered.<br /><br /><strong>Retreatment</strong><br /><br />Retreatment may be considered for patients who met the guidelines for initial treatment and subsequently developed relapse of depressive symptoms if the patient responded to prior treatments as evidenced by a greater than 50% improvement in standard rating scale measurements for depressive symptoms.</p>\"": {
    "lcd_id": "<p>All other uses of Transcranial Magnetic Stimulation are experimental and are not covered.<br /><br /><strong>Retreatment</strong><br /><br />Retreatment may be considered for patients who met the guidelines for initial treatment and subsequently developed relapse of depressive symptoms if the patient responded to prior treatments as evidenced by a greater than 50% improvement in standard rating scale measurements for depressive symptoms.</p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "Other Contractors LCDs",
    "coding_summary": "2022-09-01 00:00:00",
    "documentation_summary": ""
  },
  "<p><br />Many experts recommend that the temporary neurostimulator be placed in an ASC or outpatient hospital setting. However": {
    "lcd_id": "<p><br />Many experts recommend that the temporary neurostimulator be placed in an ASC or outpatient hospital setting. However",
    "display_id": "",
    "title": " equipment",
    "status": "",
    "effective_date": " the patie",
    "contractors": [],
    "indication_summary": "and show some element of functional improvement. (Patients with reflex sympathetic dystrophy may show lower levels of improvement since it takes longer periods for improvement than the typical 1-2 week trial). Physician judgment and experience will also be taken into account. Physicians with a low trial to permanent implant ratio (less than 50%) will be subject to post-payment review and may be asked to submit documentation as to the patient selection criteria",
    "diagnoses_summary": "the radiologic imaging demonstrating proper lead placement",
    "coding_summary": "a repeat trial is not appropriate unless there are extenuating circumstances that lead to trial failure. \"",
    "documentation_summary": ""
  },
  "<p><u>Applicable Tests/Assays</u><br /><br />In addition to the MDT definition": {
    "lcd_id": "<p><u>Applicable Tests/Assays</u><br /><br />In addition to the MDT definition",
    "display_id": "",
    "title": " including combinations of method-based",
    "status": "",
    "effective_date": " Helvetica",
    "contractors": [],
    "indication_summary": "sans-serif; font-size: 14px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: #ffffff; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal; text-decoration-style: initial; text-decoration-color: initial;\"\">Not Otherwise Classified NOC code Unique Test Identifier Requirement Because the available language in the current HIPAA compliant code sets used",
    "diagnoses_summary": "all MDT services must include an identifier as additional claim documentation. Test providers must receive an identifier specific to the applicable test and submit the test assigned identifier with the claim for reimbursement. The assigned identifier will provide a crosswalk between the test\u2019s associated detail information on file and the submitted claim detail line(s) required to adjudicate each test\u2019s claim. The unique identifier limits the need to submit the required additional information ab",
    "coding_summary": "go to the Noridian Medicare home page at noridianmedicare.com and select MolDX \u00ae under the Policies Tab. MolDX \u00ae expects laboratory providers to follow test indications published by the developer. \"",
    "documentation_summary": ""
  },
  "<p>In accordance with CMS Ruling 95-1 (V)": {
    "lcd_id": "<p>In accordance with CMS Ruling 95-1 (V)",
    "display_id": "",
    "title": " oximetric determinations once or twice a year are considered reasonable.<br /><br />In all instances",
    "status": "",
    "effective_date": " acute bro",
    "contractors": [],
    "indication_summary": "for coverage purposes. Only one service (oximetry determination) per day will be allowed for testing at a reasonable frequency and if medically necessary regardless of whether the patient is sitting",
    "diagnoses_summary": "standing or lying",
    "coding_summary": "when there is documentation of an acute exacerbation of a chronic pulmonary disease or other acute illnesses with signs indicating or suggesting increased hypoxemia. \"",
    "documentation_summary": ""
  },
  "<p>When used in combination with other biologics": {
    "lcd_id": "<p>When used in combination with other biologics",
    "display_id": "2024-08-01 11:47:38.990000000",
    "title": " Kineret<sup>&reg;</sup> (anakinra)",
    "status": "",
    "effective_date": " Cimzia<su",
    "contractors": [],
    "indication_summary": "or a Janus kinase inhibitor [e.g. Xeljanz \u00ae (tofacitinib)]",
    "diagnoses_summary": "infliximab is considered not medically reasonable and necessary and therefore",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>Intersocietal Accreditation Commission. (2013": {
    "lcd_id": "<p>Intersocietal Accreditation Commission. (2013",
    "display_id": "",
    "title": " pages 1-67.</p>\"",
    "status": "",
    "effective_date": "2015-07-01",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "2023-10-04 00:00:00",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br /><br /><br />It is anticipated only allopathic or osteopathic physicians will have the necessary training to meet these requirements.</p>\"": {
    "lcd_id": "<p><br /><br /><br />It is anticipated only allopathic or osteopathic physicians will have the necessary training to meet these requirements.</p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). \"Somatosensory Evoked Potentials: Clinical Uses\". Chapter 5. Muscle Nerve 22: Supplement 8: S111-S118, 1999. Accessed August 2014 at AANEM.org website. American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). \u201cPosition Statement - Recommended Policy for Electrodiagnostic Medicine\u201d. Accessed August 2014 at AANEM.org website.",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p style=\"\"padding-left: 30px;\"\">Systemic arthropathy such as ankylosing spondylitis or rheumatoid arthritis;<br /><br />Generalized pain behavior (e.g. somatoform disorder) or generalized pain disorder (e.g. fibromyalgia);<br /><br />Infection": {
    "lcd_id": "<p style=\"\"padding-left: 30px;\"\">Systemic arthropathy such as ankylosing spondylitis or rheumatoid arthritis;<br /><br />Generalized pain behavior (e.g. somatoform disorder) or generalized pain disorder (e.g. fibromyalgia);<br /><br />Infection",
    "display_id": "",
    "title": " or fracture;<br /><br />Acute",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><span style=\"\"display: inline !important; float: none; background-color: #ffffff; color: #333333; font-family: Verdana": {
    "lcd_id": "<p><span style=\"\"display: inline !important; float: none; background-color: #ffffff; color: #333333; font-family: Verdana",
    "display_id": "N",
    "title": "Helvetica",
    "status": "",
    "effective_date": " Medicare ",
    "contractors": [],
    "indication_summary": "\u00a713.5.4 Reasonable and Necessary Provisions in LCDs \"",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><strong> Equipment for Autonomic Nervous System Studies:</strong> <br /><br />Equipment with FDA clearance for heart rate variability measurements in response to paced respirations and exercises that tests only heart rate variability does not meet the full range of testing parameters required for testing of autonomic nervous system function; cardiovagal innervation and vasomotor adrenergic innervation": {
    "lcd_id": "<p><strong> Equipment for Autonomic Nervous System Studies:</strong> <br /><br />Equipment with FDA clearance for heart rate variability measurements in response to paced respirations and exercises that tests only heart rate variability does not meet the full range of testing parameters required for testing of autonomic nervous system function; cardiovagal innervation and vasomotor adrenergic innervation",
    "display_id": "",
    "title": " such as blood pressure monitoring and blood oxygen levels; nor do they incorporate proper testing conditions",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "Other Contractor LCD (Wisconsin Physicians Service) (LCD ID L35174) which includes the following sources: Gunal D, Afsar N, Tanridag T, Aktan S. Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. European Neurology [serial online]. 2002;48(1):1-5. Illigens, Ben M W, and Christopher H Gibbons. \"Sweat testing to evaluate autonomic function.\" Clinical Autonomic Research: Official Journal Of The Clinical Autonomic Research Society. 2009;19(2):79-87. Iodice V, L",
    "documentation_summary": ""
  },
  "<p><br />For outpatient settings other than a Comprehensive Outpatient Rehabilitation Facility (CORF)": {
    "lcd_id": "<p><br />For outpatient settings other than a Comprehensive Outpatient Rehabilitation Facility (CORF)",
    "display_id": "A",
    "title": " such as nurse practitioners",
    "status": "",
    "effective_date": " order and",
    "contractors": [],
    "indication_summary": "410.75",
    "diagnoses_summary": "410.76 and 419.22; 58 FR 18543",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br />Noridian expects that the evaluation of primary hypogonadism be undertaken with at least 2 separate serum testosterone levels taken on two different days in the morning (when testosterone secretion is highest) ": {
    "lcd_id": "<p><br />Noridian expects that the evaluation of primary hypogonadism be undertaken with at least 2 separate serum testosterone levels taken on two different days in the morning (when testosterone secretion is highest) ",
    "display_id": "",
    "title": " pituitary disease (including a serum prolactin) or chronic diseases should be assessed before making a diagnosis of age related low testosterone. Only patients with low testosterone associated signif",
    "status": "",
    "effective_date": " physical ",
    "contractors": [],
    "indication_summary": "or the effect of the symptoms-and there is a considerable placebo effect. Long term effects of testosterone on the geriatric population are mixed but are being studied by the NIH. Long term use of testosterone can damage the hypothalamic-pituitary-testicular axis and lead to permanent testicular failure. Testosterone replacement therapy is contraindicated in patients with breast cancer and untreated prostate cancer. There are recent FDA listed warnings about thromboembolic disease",
    "diagnoses_summary": "increase in erythrocythemia",
    "coding_summary": "the risk of supraphysiological or subtherapeutic levels is minimized. The use of topical agents is thought to minimize adverse events. Indeed",
    "documentation_summary": "in series examining the toxicity of topical agents"
  },
  "<p>The globally billed professional/technical (PC/TC) components for services related to home sleep testing are covered for the purpose of testing a patient for the diagnosis of OSA if the home sleep testing is reasonable and necessary for the diagnosis of the patient&rsquo;s condition": {
    "lcd_id": "<p>The globally billed professional/technical (PC/TC) components for services related to home sleep testing are covered for the purpose of testing a patient for the diagnosis of OSA if the home sleep testing is reasonable and necessary for the diagnosis of the patient&rsquo;s condition",
    "display_id": "",
    "title": " and the physician who performs the service meets the physician training/certification requirement.<br /><br /><strong>Technologist/Technician Credentials/Training</strong> <br /><br />&bull; Sleep te",
    "status": "",
    "effective_date": " who are n",
    "contractors": [],
    "indication_summary": "ABSM",
    "diagnoses_summary": "NBRC or other accepted certification body",
    "coding_summary": "the PC/TC for HST can be covered for the purpose of testing a patient for the diagnosis of OSA if the home sleep testing is reasonable and necessary for the diagnosis of the patient\u2019s condition as outlined in the LCD; and the office-based technician doing the patient instruction and HST scoring meet the training/credentialing requirements as outlined above. Under this circumstance",
    "documentation_summary": "the physician would be the interpreter of the test and bill globally. \""
  },
  "<p>The patient's record demonstrates why Proton beam radiotherapy is considered the treatment of choice for the individual patient. Specifically": {
    "lcd_id": "<p>The patient's record demonstrates why Proton beam radiotherapy is considered the treatment of choice for the individual patient. Specifically",
    "display_id": "N",
    "title": " the lower risk of disease recurrence",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": "Agency for Healthcare Research and Quality; AHRQ; Particle Beam Radiation Therapies for Cancer Publication No. 09-EHC019-EF; Revised November 2009 Agency for Healthcare Research and Quality; Comparative effectiveness of therapies for clinically localized prostate cancer; Feb 2008 Allen A et al., Fatal Pneumonitis Associated With Intensity-Modulated Radiation Therapy For Mesothelioma. Int. J. Radiation Oncology Biol. Phys. 2006, 65(3):640-5. American College of Radiology (ACR) - ASTRO practice pa"
  },
  "<p><br /><strong> Limitations: </strong><br /><br />Testing may not be used for routine or other screening.<br /><br />Both assays of vitamin D need not be performed for each of the above conditions. Often": {
    "lcd_id": "<p><br /><strong> Limitations: </strong><br /><br />Testing may not be used for routine or other screening.<br /><br />Both assays of vitamin D need not be performed for each of the above conditions. Often",
    "display_id": "",
    "title": " 25-dihydroxy vitamin D deficiency exists; mostly",
    "status": "",
    "effective_date": " 25-dihydr",
    "contractors": [],
    "indication_summary": "does not necessarily reflect deficiency of 25-OH vitamin D and its measurement should be limited to the indications listed. Documentation must justify the test(s) chosen for a particular disease entity. Various component sources of 25-OH vitamin D",
    "diagnoses_summary": "such as stored D or diet-derived D",
    "coding_summary": "documentation most clearly indicate the necessity of the test. If level <20 ng/ml or > 60 ng/ml",
    "documentation_summary": "a subsequent level(s) may be reimbursed until the level is within the normal range. \""
  },
  "<p><span style=\"\"line-height: 107%;\"\">The use of ultrasound guidance in conjunction with these non-covered injections is also considered not medically necessary and will result in denial.</span><br /><br />Note: the term \"\"Morton's neuroma\"\" is used in this document generically to refer to a swollen inflamed nerve in the ball of the foot": {
    "lcd_id": "<p><span style=\"\"line-height: 107%;\"\">The use of ultrasound guidance in conjunction with these non-covered injections is also considered not medically necessary and will result in denial.</span><br /><br />Note: the term \"\"Morton's neuroma\"\" is used in this document generically to refer to a swollen inflamed nerve in the ball of the foot",
    "display_id": "2019-11-15 15:50:07.073000000",
    "title": " Heuter's neuroma (first intermetatarsal space)",
    "status": "",
    "effective_date": " ligaments",
    "contractors": [],
    "indication_summary": "peripheral nerves",
    "diagnoses_summary": "tendon sheaths and their origins/insertions",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>CMS Internet-Only Manual": {
    "lcd_id": "<p>CMS Internet-Only Manual",
    "display_id": "Y",
    "title": " Medicare Benefit Policy Manual<em>",
    "status": "",
    "effective_date": " and Other",
    "contractors": [],
    "indication_summary": "BlinkMacSystemFont",
    "diagnoses_summary": "'Segoe UI'",
    "coding_summary": "Cantarell",
    "documentation_summary": "'Open Sans'"
  },
  "<p>This policy provides limited coverage for the Envisia&trade; Genomic Classifier (Veracyte&trade;": {
    "lcd_id": "<p>This policy provides limited coverage for the Envisia&trade; Genomic Classifier (Veracyte&trade;",
    "display_id": "2023-06-22 12:04:03.517000000",
    "title": " South San Francisco",
    "status": "",
    "effective_date": " or other ",
    "contractors": [],
    "indication_summary": "and is intended to provide a categorical UIP or non-UIP result",
    "diagnoses_summary": "that along with clinical and radiographic information",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p><br /><strong>Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment<br /><br /></strong>In this study": {
    "lcd_id": "<p><br /><strong>Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment<br /><br /></strong>In this study",
    "display_id": "",
    "title": " 2017",
    "status": "",
    "effective_date": " and Evalu",
    "contractors": [],
    "indication_summary": "2017",
    "diagnoses_summary": "were randomized controlled trials",
    "coding_summary": "gamma Knife thalamotomy",
    "documentation_summary": "or control intervention. The evidence shows that MRgFUS neurosurgery is generally safe and effective at reducing tremor severity"
  },
  "<p style=\"\"line-height: normal;\"\">* Cancer Diagnostic strategies refer to the measures taken to investigate persons with symptoms suspicious for malignancy or as a result of positive screening tests. Cancer Surveillance refers to the interval utilization of diagnostic strategies in people with previously detected cancerous or pre-cancerous lesions. Cancer Screening strategies refer to those measures taken to diagnose cancerous and pre-cancerous lesions in asymptomatic people with no previous history of such.</p>\"": {
    "lcd_id": "<p style=\"\"line-height: normal;\"\">* Cancer Diagnostic strategies refer to the measures taken to investigate persons with symptoms suspicious for malignancy or as a result of positive screening tests. Cancer Surveillance refers to the interval utilization of diagnostic strategies in people with previously detected cancerous or pre-cancerous lesions. Cancer Screening strategies refer to those measures taken to diagnose cancerous and pre-cancerous lesions in asymptomatic people with no previous history of such.</p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p style=\"\"text-align: left; color: #212529; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: Verdana": {
    "lcd_id": "<p style=\"\"text-align: left; color: #212529; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: Verdana",
    "display_id": "",
    "title": " Helvetica",
    "status": "",
    "effective_date": " Helvetica",
    "contractors": [],
    "indication_summary": "sans-serif; font-size: 14px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; text-decoration-thickness: initial;\"\">CMS Internet-Only Manual",
    "diagnoses_summary": "Pub. 100-02",
    "coding_summary": "Diagnostic Laboratory",
    "documentation_summary": "and Other Diagnostic Tests"
  },
  "<p>CTP has the advantage of being able to be performed by most multi-slice scanners and add minimal time": {
    "lcd_id": "<p>CTP has the advantage of being able to be performed by most multi-slice scanners and add minimal time",
    "display_id": "",
    "title": " to the evaluation. There are limitations to CPT technology",
    "status": "",
    "effective_date": " which may",
    "contractors": [],
    "indication_summary": "the software programs would be standardized",
    "diagnoses_summary": "but given the variability",
    "coding_summary": "which can be caused by low cardiac output",
    "documentation_summary": "arrhythmias"
  },
  "<p>Rituximab is considered investigational for Sjorgren&rsquo;s syndrome.</p>\"": {
    "lcd_id": "<p>Rituximab is considered investigational for Sjorgren&rsquo;s syndrome.</p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "2021-06-24 00:00:00",
    "documentation_summary": ""
  },
  "<p><span style=\"\"background: white;\"\">Supply allowance HCPCS codes (B4034": {
    "lcd_id": "<p><span style=\"\"background: white;\"\">Supply allowance HCPCS codes (B4034",
    "display_id": "<p><strong>DOCUMENTATION REQUIREMENTS</strong><br />Section 1833(e) of the Social Security Act precludes payment to any provider of services unless \"there has been furnished such information as may be necessary in order to determine the amounts due such provider.&rdquo; It is expected that the beneficiary's medical records will reflect the need for the care provided. The beneficiary's medical records include the treating practitioner's office records, hospital records, nursing home records, home health agency records, records from other healthcare professionals and test reports. This documentation must be available upon request.<br /><br /><strong>GENERAL DOCUMENTATION REQUIREMENTS</strong><br /><br />In order to justify payment for DMEPOS items, suppliers must meet the following requirements:</p>",
    "title": " B4036",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>A Multi-jurisdictional contract advisory committee meeting of subject matter experts (SMEs) was convened on 02/11/2021 regarding epidural injections and procedures. The transcript": {
    "lcd_id": "<p>A Multi-jurisdictional contract advisory committee meeting of subject matter experts (SMEs) was convened on 02/11/2021 regarding epidural injections and procedures. The transcript",
    "display_id": "N",
    "title": " and audio are available on each MACs website. The panel consisted of experts in pain management including anesthesiology and physical medicine and rehabilitation",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p style=\"\"line-height: normal;\"\">&nbsp;</p>\"": {
    "lcd_id": "<p style=\"\"line-height: normal;\"\">&nbsp;</p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "2024-10-31 00:00:00",
    "documentation_summary": ""
  },
  "<p>Commercially available at the time of this LCD includes a novel": {
    "lcd_id": "<p>Commercially available at the time of this LCD includes a novel",
    "display_id": "",
    "title": " Newport",
    "status": "",
    "effective_date": " and micro",
    "contractors": [],
    "indication_summary": "homocysteine",
    "diagnoses_summary": "pyroglutamic acid",
    "coding_summary": "ethylmalonate",
    "documentation_summary": "3- hydroxypropyl mercapturic acid (3- HPMA)"
  },
  "<p><span style=\"\"line-height: 115%;\"\">Grade D-One (or more) mucosal break which involves at least 75% of the esophageal circumference</span></p>\"": {
    "lcd_id": "<p><span style=\"\"line-height: 115%;\"\">Grade D-One (or more) mucosal break which involves at least 75% of the esophageal circumference</span></p>\"",
    "display_id": "",
    "title": "",
    "status": "",
    "effective_date": "",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "2024-05-30 00:00:00",
    "documentation_summary": ""
  },
  "<p><span style=\"\"line-height: 115%;\"\">McGuire RA": {
    "lcd_id": "<p><span style=\"\"line-height: 115%;\"\">McGuire RA",
    "display_id": "",
    "title": " Donahoe K. Dual fibular allograft dowel technique for sacroiliac joint arthrodesis. <em>Evid Based Spine Care J</em>. 2012;3(3):21-28.</span></p>\"",
    "status": "",
    "effective_date": "2025-01-02",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>McGuire RA": {
    "lcd_id": "<p>McGuire RA",
    "display_id": "",
    "title": " Donahoe K. Dual fibular allograft dowel technique for sacroiliac joint arthrodesis. <em>Evid Based Spine Care J</em>. 2012;3(3):21-28.</p>\"",
    "status": "",
    "effective_date": "2025-01-02",
    "contractors": [],
    "indication_summary": "",
    "diagnoses_summary": "",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>Free standing facilities (office or clinic)": {
    "lcd_id": "<p>Free standing facilities (office or clinic)",
    "display_id": "<p>This Local Coverage Determination (LCD) supplements but does not replace, modify, or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for the use of superficial radiation therapy (SRT) for the treatment of Nonmelanoma Skin Cancers (NMSCs). Federal Statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. They are not repeated in this LCD. Neither Medicare payment policy rules nor this LCD replace, modify, or supersede applicable state statutes regarding medical practice or other health practice professions acts, definitions and scopes of practice. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations, and rules for Medicare payment for the delivery of radiation therapy (RT) services for the treatment of NMSCs. In addition, any applicable state laws must be followed for the safe delivery of RT to the beneficiary including any structural requirements where RT is delivered and any applicable supervision or training requirements for staff participating in the delivery of radiation services. Finally, the RT services must be within the physician&rsquo;s scope of practice and consistent with any additional state regulations and guidelines. Relevant Federal and CMS guidelines are noted below, and CMS Internet-Only Manuals (IOMs) policies may be found published on the CMS Web site.</p>",
    "title": " radiation oncologist",
    "status": "",
    "effective_date": " supervisi",
    "contractors": [],
    "indication_summary": "for Medicare and the Nuclear Regulatory Commission (NRC)",
    "diagnoses_summary": "as applicable. \"",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p style=\"\"line-height: 107%;\"\"><span style=\"\"line-height: 107%;\"\">Free standing facilities (office or clinic)": {
    "lcd_id": "<p style=\"\"line-height: 107%;\"\"><span style=\"\"line-height: 107%;\"\">Free standing facilities (office or clinic)",
    "display_id": "<p>This Local Coverage Determination (LCD) supplements but does not replace, modify, or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for the use of superficial radiation therapy (SRT) for the treatment of Nonmelanoma Skin Cancers (NMSCs). Federal Statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. They are not repeated in this LCD. Neither Medicare payment policy rules nor this LCD replace, modify, or supersede applicable state statutes regarding medical practice or other health practice professions acts, definitions and scopes of practice. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations, and rules for Medicare payment for the delivery of radiation therapy (RT) services for the treatment of NMSCs. In addition, any applicable state laws must be followed for the safe delivery of RT to the beneficiary including any structural requirements where RT is delivered and any applicable supervision or training requirements for staff participating in the delivery of radiation services. Finally, the RT services must be within the physician&rsquo;s scope of practice and consistent with any additional state regulations and guidelines. Relevant Federal and CMS guidelines are noted below, and CMS Internet-Only Manuals (IOMs) policies may be found published on the CMS Web site.</p>",
    "title": "</span> <span style=\"\"line-height: 107%;\"\">radiation oncologist",
    "status": "",
    "effective_date": " supervisi",
    "contractors": [],
    "indication_summary": "for Medicare and the Nuclear Regulatory Commission (NRC)",
    "diagnoses_summary": "as applicable. \"",
    "coding_summary": "",
    "documentation_summary": ""
  },
  "<p>For purposes of Centers for Medicare and Medicaid Services (CMS)": {
    "lcd_id": "<p>For purposes of Centers for Medicare and Medicaid Services (CMS)",
    "display_id": "P",
    "title": " Radiation Oncology OR by a qualified dermatology program of training with didactic and clinical experience in radiation treatment).<br />Free standing facilities (office or clinic)",
    "status": "",
    "effective_date": " radiation",
    "contractors": [],
    "indication_summary": "supervising",
    "diagnoses_summary": "and treating patients for the indications outlined in this LCD meet the regulations set forth for the state",
    "coding_summary": "",
    "documentation_summary": ""
  }
}